Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Perspective Therapeutics, Inc. (CATX) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.21M |
|
$-25.97M |
|
-- |
|
$0.21M |
|
$28.07M |
|
$-27.86M |
|
$1.89M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-25.97M |
|
$-27.86M |
|
$-27.64M |
|
74.30M |
|
74.30M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$178.50M |
|
$64.35M |
|
$116.33M |
|
$294.82M |
|
$20.62M |
|
$1.58M |
|
$31.99M |
|
$52.61M |
|
$242.22M |
|
$192.22M |
|
$242.22M |
|
74.34M |
|
| Cash Flow Statement Financials | |
$-57.83M |
|
$12.69M |
|
$10.32M |
|
$61.58M |
|
$26.76M |
|
$-34.82M |
|
$6.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.66 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.01 |
100.00% |
|
-13330.62% |
|
-13330.62% |
|
-- |
|
-12425.36% |
|
-12425.36% |
|
$-65.50M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.17 |
|
77.08 |
|
-10.72% |
|
-13.51% |
|
-8.81% |
|
-10.65% |
|
$3.26 |
|
$-0.88 |
|
$-0.78 |
|